Ocean Biomedical Inc.
Ocean Biomedical, Inc., a biopharmaceutical company, focuses on discovering and developing therapeutic products in oncology, fibrosis, and infectious diseases in the United States. The company develops an antibody therapeutic product candidate inhibiting Chi3l1, and a bi-specific antibody product candidate inhibiting Chi3l1 plus PD-1 and CTLA-4 for the treatment of non-small cell lung cancer and … Read more
Market Cap & Net Worth: Ocean Biomedical Inc. (OCEA)
Ocean Biomedical Inc. (NASDAQ:OCEA) has a market capitalization of $1.63 Million ($1.63 Million) as of March 19, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #35257 globally and #11490 in its home market, demonstrating a -77.73% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Ocean Biomedical Inc.'s stock price $0.01 by its total outstanding shares 166011008 (166.01 Million).
Ocean Biomedical Inc. Market Cap History: 2021 to 2025
Ocean Biomedical Inc.'s market capitalization history from 2021 to 2025. Data shows change from $1.66 Billion to $1.63 Million (-86.48% CAGR).
Index Memberships
Ocean Biomedical Inc. is a constituent of 2 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
NASDAQ Health Care
IXHC
|
$2.24 Trillion | 0.00% | #882 of 976 |
|
NASDAQ Composite
IXIC
|
$33.39 Trillion | 0.00% | #2777 of 3165 |
Weight: Ocean Biomedical Inc.'s market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Ocean Biomedical Inc. Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Ocean Biomedical Inc.'s valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of OCEA by Market Capitalization
Companies near Ocean Biomedical Inc. in the global market cap rankings as of March 19, 2026.
Key companies related to Ocean Biomedical Inc. by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #162 globally with a market cap of $117.09 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #281 globally with a market cap of $74.80 Billion USD.
- CSL Limited (PINK:CMXHF): Ranked #344 globally with a market cap of $63.46 Billion USD.
- argenx SE (OTCGREY:ARGNF): Ranked #500 globally with a market cap of $42.99 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #162 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $117.09 Billion | $462.49 |
| #281 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $74.80 Billion | $759.05 |
| #344 | CSL Limited | PINK:CMXHF | $63.46 Billion | $149.87 |
| #500 | argenx SE | OTCGREY:ARGNF | $42.99 Billion | $697.42 |
Ocean Biomedical Inc. Historical Marketcap From 2021 to 2025
Between 2021 and today, Ocean Biomedical Inc.'s market cap moved from $1.66 Billion to $ 1.63 Million, with a yearly change of -86.48%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | $1.63 Million | -98.23% |
| 2024 | $91.80 Million | -16.21% |
| 2023 | $109.57 Million | -93.65% |
| 2022 | $1.73 Billion | +4.10% |
| 2021 | $1.66 Billion | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Ocean Biomedical Inc. was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $1.63 Million USD |
| MoneyControl | $1.63 Million USD |
| MarketWatch | $1.63 Million USD |
| marketcap.company | $1.63 Million USD |
| Reuters | $1.63 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.